Relay Therapeutics 2024 Annual Meeting: Director Elections & Executive Pay Vote
Ticker: RLAY · Form: DEF 14A · Filed: Apr 23, 2024 · CIK: 1812364
| Field | Detail |
|---|---|
| Company | Relay Therapeutics, Inc. (RLAY) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance, executive-compensation
Related Tickers: RLAY
TL;DR
RLAY proxy meeting June 3rd: vote on directors, exec pay, and auditor. Register by June 1st.
AI Summary
Relay Therapeutics, Inc. is holding its 2024 Annual Meeting of Stockholders online on June 3, 2024, at 1:30 p.m. ET. Key agenda items include electing two Class I directors, an advisory vote on executive compensation, and ratifying the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Stockholders must register by June 1, 2024, at 5:00 p.m. ET to attend and vote.
Why It Matters
This filing outlines the key decisions shareholders will make regarding board composition and executive compensation, directly impacting the company's governance and future direction.
Risk Assessment
Risk Level: low — This is a standard annual proxy statement detailing routine corporate governance matters.
Key Numbers
- 2 — Directors to be Elected (Shareholders will vote on electing two Class I directors.)
Key Players & Entities
- Relay Therapeutics, Inc. (company) — Registrant
- June 3, 2024 (date) — Date of Annual Meeting
- June 1, 2024 (date) — Registration Deadline
- Ernst & Young LLP (company) — Independent Registered Public Accounting Firm
FAQ
When and how will the 2024 Annual Meeting of Stockholders be held?
The meeting will be held online on June 3, 2024, at 1:30 p.m. Eastern Time, conducted via live webcast.
What is the deadline for stockholders to register for the virtual meeting?
Stockholders must register by June 1, 2024, at 5:00 p.m. Eastern Time at www.proxydocs.com/RLAY.
What are the primary purposes of the Annual Meeting?
The purposes include electing two Class I directors, an advisory vote on executive compensation, and ratifying the appointment of Ernst & Young LLP as the independent auditor.
Who is being proposed for election as Class I directors?
The filing states that two Class I directors will be elected, but their names are not specified in this excerpt.
What is the fiscal year for which Ernst & Young LLP's appointment is being ratified?
The appointment is being ratified for the fiscal year ending December 31, 2024.
Filing Stats: 4,914 words · 20 min read · ~16 pages · Grade level 12.2 · Accepted 2024-04-23 16:05:25
Key Financial Figures
- $0.001 — 1 shares of our common stock, par value $0.001 per share, outstanding on April 4, 2024
Filing Documents
- rlay-20240422.htm (DEF 14A) — 2020KB
- img68939711_0.jpg (GRAPHIC) — 161KB
- img68939711_1.jpg (GRAPHIC) — 161KB
- img68939711_2.jpg (GRAPHIC) — 650KB
- img68939711_3.jpg (GRAPHIC) — 528KB
- img68939711_4.jpg (GRAPHIC) — 518KB
- img68939711_5.jpg (GRAPHIC) — 381KB
- img68939711_6.jpg (GRAPHIC) — 896KB
- img68939711_7.jpg (GRAPHIC) — 552KB
- 0000950170-24-046883.txt ( ) — 12839KB
- rlay-20240422.xsd (EX-101.SCH) — 56KB
- rlay-20240422_htm.xml (XML) — 531KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 21 CEO PAY RATIO 46 pay versus performance 47 DIRECTOR COMPENSATION 52 PROPOSAL 2 – NON-BINDING ADVISORY VOTE ON COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS 54 PROPOSAL 3 – RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS RELAY THERAPEUTICS' INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024 55 REPORT OF THE AUDIT COMMITTEE 57 EQUITY COMPENSATION PLAN INFORMATION 58 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 59 PRINCIPAL STOCKHOLDERS 60 HOUSEHOLDING 63 STOCKHOLDER PROPOSALS 63 OTHER MATTERS 63 RELAY THERAPEUTICS, INC. 399 Binney Street, 2nd Floor Cambridge, MA 02139 PROXY ST ATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS to be held June 3, 2024 This proxy statement contains information about the 2024 Annual Meeting of Stockholders, or the Annual Meeting, of Relay Therapeutics, Inc., which will be held on June 3, 2024 at 1:30 p.m. Eastern Time. The Annual Meeting will be a virtual meeting, which will be conducted via live webcast. You will be able to attend the meeting online, vote electronically and submit questions by registering at www.proxydocs.com/RLAY prior to the deadline of June 1, 2024 at 5:00 p.m. Eastern Time. The board of directors of Relay Therapeutics, Inc. is using this proxy statement to solicit proxies for use at the Annual Meeting. In this proxy statement, the terms "Relay Therapeutics," the "Company," "we," "us," and "our" refer to Relay Therapeutics, Inc. The mailing address of our principal executive office is Relay Therapeutics, Inc., 399 Binney Street, 2 nd Floor, Cambridge, Massachusetts 02139. In order to attend the Annual Meeting virtually, you must register in advance at www.proxydocs.com/RLAY prior to the deadline of June 1, 2024 at 5:00 p.m. Eastern Time. You will be required to enter the control number provided in the Notice of Internet Availability of Proxy Materials, or Notice of Availa